Products

Online Inquiry

As a CRO specializing in cardiovascular disease research, Ace Therapeutics offers a range of inhibitors & activators to study and understand the mechanisms underlying various cardiovascular conditions. These compounds play a crucial role in drug discovery and the development of potential therapies.

Inhibitors & Activators

PKG1α activator 3 (CDIA-2035) Inquiry
Formula:
C27H26Cl2N2O6
Molecular Weight:
545.41

(1R, 3S)-THCCA-Asn (CDIA-2036) Inquiry
Formula:
C24H24N4O6
Molecular Weight:
464.47

FXIa-IN-10 (CDIA-2037) Inquiry
Formula:
C23H18Cl2F3N9O2
CAS Number:
2816108-08-2
Molecular Weight:
580.35

DCZ19931 (CDIA-2038) Inquiry
Formula:
C26H20F5N3O5
CAS Number:
2789629-84-9
Molecular Weight:
549.45

Tubulin polymerization-IN-39 (CDIA-2039) Inquiry
Formula:
C21H21N5O5
Molecular Weight:
423.42

FXIa-IN-9 (CDIA-2040) Inquiry
Formula:
C23H18Cl2F3N9O2
CAS Number:
2816108-87-7
Molecular Weight:
580.35

Tadalafil-d3 (CDIA-2041) Inquiry
Formula:
C22H16D3N3O4
CAS Number:
960226-55-5
Molecular Weight:
392.42

Cinacalcet-d3 (CDIA-2043) Inquiry
Formula:
C22H19D3F3N
Molecular Weight:
360.43

Phenindione-d5 (CDIA-2044) Inquiry
Formula:
C15H5D5O2
CAS Number:
70711-53-4
Molecular Weight:
227.27

Dofetilide-d4 (CDIA-2045) Inquiry
Formula:
C19H23D4N3O5S2
CAS Number:
1189700-56-8
Molecular Weight:
445.59

! For research use only. Not intended for any clinical use.